trimonil retard 300 mg
orifarm as - karbamazepin - depottablett - 300 mg
xalatan 50 mikrog/ ml
upjohn eesv - latanoprost - Øyedråper, oppløsning - 50 mikrog/ ml
heminevrin 300 mg
cheplapharm arznemittel gmbh - klometiazoldisylat - kapsel, myk - 300 mg
heminevrin 50 mg/ ml
cheplapharm arznemittel gmbh - klometiazoldisylat - mikstur, oppløsning - 50 mg/ ml
tagrisso
astrazeneca ab - osimertinib mesilate - karsinom, ikke-småcellet lunge - andre cytostatika, protein kinase hemmere - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
carbamazepine essential pharma 125 mg
essential pharma (m) limited - karbamazepin - stikkpille - 125 mg
carbamazepine essential pharma 250 mg
essential pharma (m) limited - karbamazepin - stikkpille - 250 mg
efient 10 mg
2care4 - prasugrel - tablett, filmdrasjert - 10 mg
tegretol 200 mg
novartis norge (2) - karbamazepin - tablett - 200 mg
tegretol 20 mg/ ml
novartis norge (2) - karbamazepin - mikstur, suspensjon - 20 mg/ ml